Home › Funds › KVP Capital Advisors, LP › DSGN

KVP Capital Advisors, LP position in DSGN

DESIGN THERAPEUTICS INC · Health Care

KVP Capital Advisors, LP reported holding 185,000 shares of DSGN (DESIGN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 1.90% of its reported portfolio and ranking #21 among its reported holdings. KVP Capital Advisors, LP has disclosed DSGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)185.00K sh
Reported value held$2.33M
Portfolio Weight1.90%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's DSGN position evolved

KVP Capital Advisors, LP first disclosed a stake in DSGN in Q2 2026 at 185,000 shares (US$2.7M). Across 2 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 185,000 shares valued at US$2.3M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 185.00K $2.68M New
Q3 2026 185.00K $2.33M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DSGN and 13F data

DSGN (DESIGN THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in DSGN — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$94.4M), BAKER BROS. ADVISORS LP (US$38.8M), Trails Edge Capital Partners, LP (US$31.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DSGN

All DSGN fund holders →

FAQ

How long has KVP Capital Advisors, LP held DSGN?

KVP Capital Advisors, LP has disclosed DSGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is KVP Capital Advisors, LP's current position in DSGN?

As of Q3 2026, KVP Capital Advisors, LP holds 185.00K shares of DSGN (DESIGN THERAPEUTICS INC), valued at $2.33M, representing 1.90% of its reported portfolio and ranking #21.

Has KVP Capital Advisors, LP been buying or selling DSGN?

In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP held unchanged its position in DSGN.

Which other funds hold DSGN?

Other major institutional holders of DSGN include SR ONE CAPITAL MANAGEMENT, LP, BAKER BROS. ADVISORS LP, Trails Edge Capital Partners, LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.